Medical News: FDA Reassures on Osteoporosis Drugs - in Endocrinology, Osteoporosis (confused yet?) Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Friday, March 12, 2010

Medical News: FDA Reassures on Osteoporosis Drugs - in Endocrinology, Osteoporosis (confused yet?)



FDA Reassures on Osteoporosis Drugs

By John Gever, Senior Editor, MedPage Today
Published: March 10, 2010
Reviewed by Zalman S. Agus, MD; Emeritus Professor
University of Pennsylvania School of Medicine.
Click  here to rate this report
"Bisphosphonate drugs for osteoporosis do not seem to increase the risk of femoral fractures, the FDA announced Wednesday, though the agency will continue to evaluate that possibility.
Even as the FDA was making its announcement in Washington, orthopedic surgeons gathered in New Orleans were hearing news of a study showing an eventual decline in bone quality among patients who took bisphosphonates for more than four years.
The FDA issued its statement as a result of case reports suggesting that "atypical" subtrochanteric femur fractures were occurring at higher-than-expected rates in women taking bisphosphonate drugs for osteoporosis....."

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.